A detailed history of Academy Capital Management Inc transactions in Provectus Biopharmaceuticals, Inc. stock. As of the latest transaction made, Academy Capital Management Inc holds 20,000 shares of PVCT stock, worth $2,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 20,000 -0.0%
Holding current value
$2,400
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.06 - $0.16 $1,200 - $3,200
20,000 New
20,000 $2,000
Q3 2020

Nov 12, 2020

BUY
$0.04 - $0.1 $800 - $2,000
20,000 New
20,000 $1,000
Q2 2020

Aug 07, 2020

SELL
$0.04 - $0.06 $800 - $1,200
-20,000 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$0.06 - $0.08 $1,200 - $1,600
20,000 New
20,000 $0
Q2 2018

Jul 26, 2018

SELL
$0.06 - $0.08 $1,200 - $1,600
-20,000 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$0.02 - $0.03 $400 - $600
20,000
20,000 $0

Others Institutions Holding PVCT

About PROVECTUS BIOPHARMACEUTICALS, INC.


  • Ticker PVCT
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 419,496,992
  • Market Cap $50.3M
  • Description
  • Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...
More about PVCT
Track This Portfolio

Track Academy Capital Management Inc Portfolio

Follow Academy Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Academy Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Academy Capital Management Inc with notifications on news.